Singapore markets close in 2 hours 14 minutes
Straits Times Index
3,259.56 -40.48 (-1.23%) Nikkei
38,202.37 -632.73 (-1.63%) Hang Seng
18,353.44 -125.93 (-0.68%) FTSE 100
8,313.67 +100.18 (+1.22%) Bitcoin USD
62,442.18 -1,194.32 (-1.88%) CMC Crypto 200
1,289.60 -5.07 (-0.39%)
Larimar Therapeutics, Inc. (LRMR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 518.69M |
| Enterprise value | 437.45M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 6.35 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -10.55 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.74 |
| 52-week change 3 | 58.79% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 13.68 |
| 52-week low 3 | 2.18 |
| 50-day moving average 3 | 8.18 |
| 200-day moving average 3 | 5.37 |
Share statistics
| Avg vol (3-month) 3 | 658.09k |
| Avg vol (10-day) 3 | 258.01k |
| Shares outstanding 5 | 63.8M |
| Implied shares outstanding 6 | 63.8M |
| Float 8 | 32.36M |
| % held by insiders 1 | 1.45% |
| % held by institutions 1 | 84.75% |
| Shares short (15 Apr 2024) 4 | 3.63M |
| Short ratio (15 Apr 2024) 4 | 7.49 |
| Short % of float (15 Apr 2024) 4 | 7.91% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.69% |
| Shares short (prior month 15 Mar 2024) 4 | 1.63M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 29 May 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -23.48% |
| Return on equity (ttm) | -38.36% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -41.45M |
| Net income avi to common (ttm) | -36.95M |
| Diluted EPS (ttm) | -0.84 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 86.79M |
| Total cash per share (mrq) | 1.36 |
| Total debt (mrq) | 5.55M |
| Total debt/equity (mrq) | 6.79% |
| Current ratio (mrq) | 9.49 |
| Book value per share (mrq) | 1.86 |
Cash flow statement
| Operating cash flow (ttm) | -33.46M |
| Levered free cash flow (ttm) | -20.84M |
© 2024 Yahoo. All rights reserved.